Magnevist

Active Ingredient(s): Gadopentetate
FDA Approved: * June 2, 1988
Pharm Company: * BERLEX
Category: Diagnostic Aid

Gadopentetic acid, sold under the brand name Magnevist, is a gadolinium-based MRI contrast agent.[1] It is usually administered as a salt of a complex of gadolinium with DTPA (diethylenetriaminepentacetate) with the chemical formula A2[Gd(DTPA)(H2O)]; when cation A is the protonated form of the amino sugar meglumine the salt goes under the name "gadopentetate dimeglumine". It was described in 1981 by Hanns-Joachim Weinmann and colleagues [3] and introduced as t... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Magnevist 469.01 mg/ml Intravenous Injection
NDC: 50419-188
Labeler:
Bayer Healthcare Pharmaceuticals Inc.